Eastham Karin
An insider at 1 company in coverage, as reported on Form 4. SEC CIK 1231845. Latest Form 4 filed Oct 28, 2026.
Roles
As stated on the filings: the relationship to the company and any officer title.
| Company | Role | Transactions | First | Latest |
|---|---|---|---|---|
| Veracyte, Inc.VCYT | Director | 3 | 2026-10-27 | 2026-10-27 |
Transactions: 3
Every transaction reported, newest first, including grants, exercises and derivative securities. Purchases and sales (codes P and S) are open-market trades. The reported price is as stated on the form.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
| Date | Company | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-10-27 | Veracyte, Inc.Director | Option exerciseStock Option (right to buy) | 10,000 | $0.00 | $0 | Form 4 |
| 2026-10-27 | Veracyte, Inc.Director | Sale | 14,850 | $50.0049 | $742.6k | Form 4 |
| 2026-10-27 | Veracyte, Inc.Director | Option exercise | 10,000 | $27.01 | $270.1k | Form 4 |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 30, 2026, 02:58 ET. Listed shows no prices and gives no investment advice.